May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Effects of second and multiple injections of intravitreal Kenalog on visual acuity and intraocular pressure.
Author Affiliations & Notes
  • R.G. Lane
    Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • R. Kaiser
    Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • Footnotes
    Commercial Relationships  R.G. Lane, None; R. Kaiser, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4096. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.G. Lane, R. Kaiser; Effects of second and multiple injections of intravitreal Kenalog on visual acuity and intraocular pressure. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4096.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe the effect of repeat injection of intravitreal Kenalog (IVK) on visual acuity and intraocular pressure (IOP). Methods: A retrospective chart review was conducted on 17 eyes from 15 patients who underwent repeat injection of IVK. One patient in the series underwent three IVK treatments. Results: The average follow–up was 160 days. The average LogMAR gain after the first IVK was 0.069 (3.5 letters Snellen equivalent). The average LogMAR gain after the second IVK was 0.015 (1 letter). The maximum IOP after the first injection was 32 and after the second was 52. 8 out of 15 patients required glaucoma medicines. One patient required a glaucoma consult for uncontrolled IOP. Conclusions: A second IVK treatment may be associated with modest visual improvement and an increased risk of IOP rise.

Keywords: diabetic retinopathy • macula/fovea • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×